198 related articles for article (PubMed ID: 18353606)
21. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
22. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy in gastric cancer.
Lim L; Michael M; Mann GB; Leong T
J Clin Oncol; 2005 Sep; 23(25):6220-32. PubMed ID: 16135489
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study.
Wang LB; Shen JG; Xu CY; Chen WJ; Song XY; Yuan XM
Hepatogastroenterology; 2008; 55(86-87):1895-8. PubMed ID: 19102417
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
[TBL] [Abstract][Full Text] [Related]
26. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
27. [Second malignancy after gastrectomy for early gastric cancer-is there any evidence that adjuvant chemotherapy for early gastric cancer causes a second malignancy ?].
Honda I; Kobayashi D; Fukumoto R; Matsushita H; Hattori M; Nagata M; Watanabe S
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1341-5. PubMed ID: 18701845
[TBL] [Abstract][Full Text] [Related]
28. [Gastric cancer].
Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Gotouda N
Gan To Kagaku Ryoho; 2006 Mar; 33(3):313-7. PubMed ID: 16531710
[TBL] [Abstract][Full Text] [Related]
29. [New insights in the adjuvant treatment of gastric cancer].
Jansen EP; Boot H; Cats A; van Coevorden F; Zoetmulder FA; Verheij M
Ned Tijdschr Geneeskd; 2004 Dec; 148(51):2529-34. PubMed ID: 15636473
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
[TBL] [Abstract][Full Text] [Related]
31. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
32. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
33. Disparities in gastric cancer chemotherapy between the East and West.
Ohtsu A; Yoshida S; Saijo N
J Clin Oncol; 2006 May; 24(14):2188-96. PubMed ID: 16682738
[TBL] [Abstract][Full Text] [Related]
34. Postoperative body-weight loss and survival after curative resection for gastric cancer.
Yu W; Seo BY; Chung HY
Br J Surg; 2002 Apr; 89(4):467-70. PubMed ID: 11952589
[TBL] [Abstract][Full Text] [Related]
35. New chemotherapy strategies for gastric cancer.
Kubota T
In Vivo; 2008; 22(3):273-8. PubMed ID: 18610735
[TBL] [Abstract][Full Text] [Related]
36. [Second primary malignancy after surgical adjuvant therapy for gastric cancer].
Fujimoto J
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2009-14. PubMed ID: 10584564
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
[TBL] [Abstract][Full Text] [Related]
38. Management of gastric cancer.
Mackay S; Hayes T; Yeo A
Aust Fam Physician; 2006 Apr; 35(4):208-11. PubMed ID: 16642236
[TBL] [Abstract][Full Text] [Related]
39. Gastric carcinoma: review of the results of treatment in a community teaching hospital.
Heemskerk VH; Lentze F; Hulsewé KW; Hoofwijk TG
World J Surg Oncol; 2007 Jul; 5():81. PubMed ID: 17659085
[TBL] [Abstract][Full Text] [Related]
40. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
